Locations
Indianapolis, IN, USA
industry
Biotechnology · DeepTech · Health
Size
1 - 10 employees
Stage
Series B
founded in
2017
Scioto Biosciences, Inc. is a biotechnology company focused on developing Activated Bacterial Therapeutics (ABT) to optimize microbiome delivery for treating autism and gastrointestinal disorders. Their innovative ABT platform enhances the efficacy of live bacterial therapeutics by leveraging the gut-brain axis, aiming to address unmet medical needs in these areas. With a strong emphasis on clinical trials, including a recent Phase Ib study for their product SB-121, Scioto is positioned to revolutionize therapeutic interventions in the microbiome space, improving the lives of patients and their caregivers.
Is this your company?
Something looks off?